Biogen, Sage Therapeutics enter $1.5 billion deal to develop, sell neurological treatments

اشترك مجانا بقناة الديار على يوتيوب (Reuters) - Biogen Inc will take a $650 million stake in Sage Therapeutics and pay $875 million in upfront payment as they jointly develop and sell treatments for neurological disorder, the two...